Download Docs
Export
Print

HEMLEVIVE

99649045 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Feb. 12, 2026
Serial No. 99649045
Examining Attorney KAREN SHEREE DERBY
Class Pharmaceutical preparations and substances for the treatment of blood disorders; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders, and blood-based diseases; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders and blood-based diseases and to be infused to a human subject; pharmaceutical preparations for cell and gene therapy for the treatment of bone marrow; pharmaceutical preparations containing cells treated with vectors encoding proteins for elongating telomeres in blood cells; pharmaceutical preparations containing blood cells treated with vectors encoding ZSCAN4 proteins for elongating telomeres in the blood cells; pharmaceutical preparations containing blood cells treated with Sendai virus vectors encoding proteins for elongating telomeres in the blood cells; 005; 006; 018; 044; 046; 051; 052
HEMLEVIVE
Case Type Trademark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 1 day, 16 hours ago
Filing Date # Docket Text
to view the full docket.